Myriad Genetics | MYGN - Stammkapital

Aktienkurs
4.35
Täglich Wechseln
-0.09 -2.03%
Monatlich
-14.03%
Jährlich
-45.63%
Q2 Prognose
4.61




Stammkapital Veränderung Datum
Agilent USD 282.7M 358K 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Bruker USD 151.94M 225K 2025-12
Danaher USD 706.9M 600K 2025-12
Hologic USD 222.57M 350K 2025-09
Illumina USD 152.8M 900K 2025-12
J&J USD 2.41B 584K 2025-09
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quest Diagnostics USD 110M 1000K 2025-12
Quidel USD 67.9M 200K 2025-09
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Veracyte USD 79.05M 377K 2025-12
Waters USD 98.08M 38.55M 2025-12